# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-122513
Filing Date
2024-11-07
Accepted
2024-11-06 17:41:01
Documents
67
Period of Report
2024-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | acad-20240930.htm iXBRL | 10-Q | 1873476
2 | EX-10.6 | acad-ex10_6.htm | EX-10.6 | 116450
3 | EX-31.1 | acad-ex31_1.htm | EX-31.1 | 10861
4 | EX-31.2 | acad-ex31_2.htm | EX-31.2 | 10999
5 | EX-32.1 | acad-ex32_1.htm | EX-32.1 | 7735
6 | EX-32.2 | acad-ex32_2.htm | EX-32.2 | 7781
7 | GRAPHIC | img94628292_0.jpg | GRAPHIC | 164469
| Complete submission text file | 0000950170-24-122513.txt |  | 7996674

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
8 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | acad-20240930.xsd | EX-101.SCH | 941098
70 | EXTRACTED XBRL INSTANCE DOCUMENT | acad-20240930_htm.xml | XML | 1423382

Mailing Address 12830 EL CAMINO REAL SUITE 400 SAN DIEGO CA 92130
Business Address 12830 EL CAMINO REAL SUITE 400 SAN DIEGO CA 92130 858-558-2871
ACADIA PHARMACEUTICALS INC (Filer) CIK: 0001070494 (see all company filings)

EIN.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50768 | Film No.: 241432413
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)